EmCell - THE WORLDS LARGEST CLINICAL EXPERIENCE IN EMBRYONIC STEM CELL TRANSPLANTATION FOR VARIOUS DISEASES AND CONDITIONS.
During a 13-year period of clinical studies of ESCT therapeutic effects, our experts, headed by Prof. Alexander Smikodub, have performed almost 2,000 transplantations in a wide range of diseases (diabetes, cancer, hematological, articular and bowel diseases, degenerative diseases of nervous system, different kinds of injuries, diseases of connective tissue and immune system, including AIDS, chronic infections and sepsis) and conditions (premature aging, male and female climax, involution and asthenic syndromes, cachexia etc.).
Used are different types of embryonic stem cells: hematopoietic, nervous, thymic, muscular, cutaneous, etc. We also work with less specialized embryonic stem cells of mesenchimal, ectodermal, and endodermal origin. Each specific stem cell type has its own special effects. The best results have been achieved through combination of different cell types, depending on mechanisms of certain diseases and stages of their progress, etc.
Clinical studies are carried out mostly by post-graduates of National Medical University at our Cell Therapy Clinic and reputable research institutions of Health Ministry and Academy of Medical Science, such as Institutes for Oncology, Endocrinology, Infectious Diseases, Pediatrics; Hematology Centers for Children and Adults, Center for Proctology, and Central Army Hospital.
We constantly make international medical community aware of our work through participation in national and international scientific conferences and congresses, patenting new methods of treatment based on ESCT application. At the same time, until recently, we tried to avoid publicity due to limited number of patients treated by ESCT methods.